MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $22,199,000 | +72.0% | 270,000 | +206.8% | 0.50% | +83.0% |
Q4 2021 | $12,909,000 | -37.1% | 88,000 | -51.1% | 0.27% | -54.7% |
Q2 2020 | $20,537,000 | +10.3% | 179,885 | -25.7% | 0.60% | +1.2% |
Q1 2020 | $18,618,000 | -17.0% | 242,200 | +39.2% | 0.59% | -17.3% |
Q4 2019 | $22,422,000 | +23.5% | 174,000 | -25.3% | 0.72% | -3.4% |
Q3 2019 | $18,153,000 | -33.4% | 233,000 | -11.9% | 0.74% | -24.4% |
Q2 2019 | $27,254,000 | +47.4% | 264,600 | +4.9% | 0.98% | +38.1% |
Q1 2019 | $18,486,000 | -50.2% | 252,200 | -71.2% | 0.71% | -52.3% |
Q4 2018 | $37,096,000 | -6.3% | 874,486 | +4.0% | 1.48% | +4.7% |
Q3 2018 | $39,607,000 | -38.2% | 840,911 | -35.3% | 1.42% | -37.0% |
Q2 2018 | $64,108,000 | +960.0% | 1,300,365 | +560.1% | 2.25% | +971.9% |
Q1 2018 | $6,048,000 | -11.6% | 197,000 | -47.5% | 0.21% | -21.9% |
Q4 2017 | $6,844,000 | +80.7% | 375,000 | +240.8% | 0.27% | +83.0% |
Q3 2015 | $3,788,000 | -69.7% | 110,049 | -72.3% | 0.15% | -64.7% |
Q2 2015 | $12,514,000 | +1196.8% | 397,660 | +1108.3% | 0.42% | +1245.2% |
Q1 2015 | $965,000 | – | 32,912 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |